Outpatient Laparoscopic Radical Prostatectomy
ConditionProstate Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
About this trial
The purpose of the study is to evaluate the incidence of surgery-related complications between Day 0 and Day 30.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male, age ≥ 18 years;
Localized prostate cancer;
Validation in a multidisciplinary consultation meeting of curative treatment;
Scheduled laparoscopic radical prostatectomy;
Disqualifiers
Surgical emergency;
Patient not eligible for ambulatory care;
Long-term curative anti-coagulant treatment;
Resident more than 100km from the clinic;
Trial population
This study is aimed at patients with prostate cancer for whom an ambulatory laparoscopic radical prostatectomy has been validated at a multidisciplinary consultation meeting. Ambulatory management is at the surgeon's discretion, according to well-defined medical procedure criteria.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Laparoscopic radical prostatectomy
Procedure/SurgeryProstate cancer may require laparoscopic radical prostatectomy, a surgical procedure performed under general anaesthetic.
Treatment groups
64 Participants
are divided into 1 treatment groupGroup A: ambulatory patient cohort1 intervention
Trial outcomes
Primary outcomes
1
Incidence of complications
The primary endpoint was the incidence of procedural complications between Day 0 and Day 30.
Time frame
30 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead sponsor
Euraxi Pharma
Collaborator
Source ClinicalTrials.gov